Immunotherapeutic approach to reduce senescent cells and alleviate senescence‐associated secretory phenotype in mice
Aging Cell · 2023-05 · 22 (5)
DOI: 10.1111/acel.13806 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 26.03.2023. Verfasst von Niraj Shrestha und 37 weiteren Autor:innen. Beteiligte Einrichtung: HCW Biologics Inc., Miramar, Florida, USA. Hauptthemen laut MEDLINE: Senescence-Associated Secretory Phenotype, Cellular Senescence. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Accumulation of senescent cells (SNCs) with a senescence‐associated secretory phenotype (SASP) has been implicated as a major source of chronic sterile inflammation leading to many age‐related pathologies. Herein, we provide evidence that a bifunctional immunotherapeutic, HCW9218, with capabilities of neutralizing TGF‐β and stimulating immune cells, can be safely administered systemically to reduce SNCs and alleviate SASP in mice. In the diabetic db/db mouse model, subcutaneous administration of HCW9218 reduced senescent islet β cells and SASP resulting in improved glucose tolerance, insulin resistance, and aging index. In naturally aged mice, subcutaneous administration of HCW9218 durably reduced the level of SNCs and SASP, leading to lower expression of pro‐inflammatory genes in peripheral organs. HCW9218 treatment also reverted the pattern of key regulatory circadian gene expression in aged mice to levels observed in young mice and impacted genes associated with metabolism and fibrosis in the liver. Single‐nucleus RNA Sequencing analysis further revealed that HCW9218 treatment differentially changed the transcriptomic landscape of hepatocyte subtypes involving metabolic, signaling, cell‐cycle, and senescence‐associated pathways in naturally aged mice. Long‐term survival studies also showed that HCW9218 treatment improved physical performance without compromising the health span of naturally aged mice. Thus, HCW9218 represents a novel immunotherapeutic approach and a clinically promising new class of senotherapeutic agents targeting cellular senescence‐associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- HCW Biologics Inc., Miramar, Florida, USA.
- Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
- Department of Pharmaceutical Sciences, Nova Southeastern University, Fort Lauderdale, Florida, USA.
ORCID-Profile: Todd A Fehniger, Peter R Rhode, Hing C Wong
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NHLBI NIH HHS
- NIAID NIH HHS
Zitieren
APA
Shrestha, N., Chaturvedi, P., Zhu, X., Dee, M. J., George, V., Janney, C., Egan, J. O., Liu, B., Foster, M., Marsala, L., Wong, P., Cubitt, C. C., Foltz, J. A., Tran, J., Schappe, T., Hsiao, K., Leclerc, G. M., You, L., Echeverri, C., …, & Wong, H. C. (2023). Immunotherapeutic approach to reduce senescent cells and alleviate senescence‐associated secretory phenotype in mice. Aging Cell, 22(5). https://doi.org/10.1111/acel.13806
Vancouver
Shrestha N, Chaturvedi P, Zhu X, Dee MJ, George V, Janney C, et al. Immunotherapeutic approach to reduce senescent cells and alleviate senescence‐associated secretory phenotype in mice. Aging Cell. 2023;22(5). doi:10.1111/acel.13806
BibTeX
@article{Shrestha2023,
author = {Shrestha, Niraj and Chaturvedi, Pallavi and Zhu, Xiaoyun and Dee, Michael J and George, Varghese and Janney, Christopher and Egan, Jack O and Liu, Bai and Foster, Mark and Marsala, Lynne and Wong, Pamela and Cubitt, Celia C and Foltz, Jennifer A and Tran, Jennifer and Schappe, Timothy and Hsiao, Karin and Leclerc, Gilles M and You, Lijing and Echeverri, Christian and Spanoudis, Catherine and Carvalho, Ana and Kanakaraj, Leah and Gilkes, Crystal and Encalada, Nicole and Kong, Lin and Wang, Meng and Fang, Byron and Wang, Zheng and Jiao, Jin-An and Muniz, Gabriela J and Jeng, Emily K and Valdivieso, Nicole and Li, Liying and Deth, Richard and Berrien-Elliott, Melissa M and Fehniger, Todd A and Rhode, Peter R and Wong, Hing C},
title = {Immunotherapeutic approach to reduce senescent cells and alleviate senescence‐associated secretory phenotype in mice},
journal = {Aging Cell},
year = {2023},
volume = {22},
number = {5},
doi = {10.1111/acel.13806}
}
EUVIMED